Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) Stock Price

PHARStock

$11.77−19.82%52W

Market Cap$833.06M

P/E287.65x

PEG Ratio—

Div yield—

Beta0.34

PHAR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-39.88%

Price vs S&P 500 (4W)-11.52%

VGM Score41.90

P/E Ratio (Annual)287.65x

P/CF (Annual)14.99x

Book Value / Share (Quarterly)$0.38

P/TBV (Annual)7.77x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)22.30%

Cash Flow / Share (Quarterly)$0.21

Price vs S&P 500 (YTD)-40.08%

Gross Margin (TTM)86.53%

Net Profit Margin (TTM)2.54%

EPS (TTM)$0.02

10-Day Avg Trading Volume8.59M

EPS Excl Extra (TTM)$0.02

Revenue Growth (5Y)12.13%

EPS (Annual)$0.00

ROI (Annual)0.73%

Gross Margin (Annual)87.90%

Net Profit Margin (5Y Avg)1.43%

Cash / Share (Quarterly)$0.22

P/E Basic Excl Extra (TTM)88.15x

Revenue Growth QoQ (YoY)-3.23%

EPS Growth (5Y)-41.47%

P/E Normalized (Annual)287.65x

ROA (Last FY)0.57%

Revenue Growth TTM (YoY)7.83%

EBITD / Share (TTM)$0.05

ROE (5Y Avg)1.16%

Operating Margin (TTM)5.03%

Cash Flow / Share (Annual)$0.08

P/B Ratio3.03x

P/B Ratio (Quarterly)3.62x

Net Income / Employee (Annual)$7,000

EV / Revenue (TTM)2.11x

Net Interest Coverage (TTM)1.99x

ROA (TTM)1.93%

EPS Growth QoQ (YoY)-63.24%

EV / EBITDA (TTM)25.38x

EPS Incl Extra (Annual)$0.00

Current Ratio (Annual)2.59x

Quick Ratio (Quarterly)2.31x

3-Month Avg Trading Volume10.56M

52-Week Price Return-19.82%

EV / Free Cash Flow (Annual)14.36x

P/E Incl Extra (TTM)88.15x

Revenue / Employee (TTM)$900,400

Tangible BV / Share (Quarterly)$0.20

P/S Ratio (Annual)2.18x

Asset Turnover (Annual)0.75x

52-Week High$1.82

Operating Margin (5Y Avg)3.49%

EPS Excl Extra (Annual)$0.00

CapEx CAGR (5Y)-45.22%

Tangible BV CAGR (5Y)10.15%

26-Week Price Return-28.64%

Quick Ratio (Annual)1.97x

13-Week Price Return-14.61%

Total Debt / Equity (Annual)0.42x

Current Ratio (Quarterly)3.01x

Enterprise Value$774.83M

Revenue / Share Growth (5Y)10.13%

Asset Turnover (TTM)0.76x

Book Value / Share Growth (5Y)6.58%

Revenue / Employee (Annual)$924,200

Inventory Turnover (Annual)0.75x

Pretax Margin (Annual)3.42%

Cash / Share (Annual)$0.26

3-Month Return Std Dev50.27%

Gross Margin (5Y Avg)89.31%

Net Income / Employee (TTM)$22,900

EBITDA CAGR (5Y)-15.39%

EBITDA Interim CAGR (5Y)-20.30%

ROE (Last FY)1.03%

Net Interest Coverage (Annual)1.99x

EPS Basic Excl Extra (Annual)$0.00

P/FCF (TTM)5.39x

Receivables Turnover (TTM)6.64x

EV / Free Cash Flow (TTM)5.09x

Total Debt / Equity (Quarterly)0.42x

EPS Incl Extra (TTM)$0.02

Receivables Turnover (Annual)9.03x

ROI (TTM)2.39%

P/S Ratio (TTM)2.24x

Pretax Margin (5Y Avg)2.91%

Revenue / Share (Annual)$0.50

Tangible BV / Share (Annual)$0.21

Forward P/E20.43x

Free OCF CAGR (5Y)-4.61%

Price vs S&P 500 (52W)-38.13%

P/E Ratio (TTM)88.15x

Year-to-Date Return-29.49%

5-Day Price Return-0.30%

EPS Normalized (Annual)$0.00

ROA (5Y Avg)0.51%

Net Profit Margin (Annual)0.76%

Month-to-Date Return14.50%

Cash Flow / Share (TTM)$-0.01

EBITD / Share (Annual)$0.05

EPS Growth (3Y)-41.82%

Operating Margin (Annual)6.87%

LT Debt / Equity (Annual)0.33x

P/CF (TTM)5.36x

ROI (5Y Avg)0.53%

P/E Excl Extra (TTM)88.15x

LT Debt / Equity (Quarterly)0.34x

EPS Basic Excl Extra (TTM)$0.02

P/TBV (Quarterly)6.88x

P/B Ratio (Annual)4.06x

Inventory Turnover (TTM)0.77x

Pretax Margin (TTM)4.32%

Book Value / Share (Annual)$0.39

Price vs S&P 500 (13W)-17.40%

Net Margin Growth (5Y)-46.77%

Beta0.34x

P/FCF (Annual)15.19x

Revenue / Share (TTM)$0.55

ROE (TTM)3.44%

52-Week Low$0.83

vGradeC

gGradeD

mGradeD

vgmGradeC

PHAR Earnings Surprise History

Q2 250.01est. -0.01

Q3 250.01est. 0.00

Q4 250.07est. 0.01

Q1 26-0.07est. 0.00

Q2 260.00est. 0.06

PHAR Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.43

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
PHARPharming Group N.V. ADS, each representing 10 ordinary shares	C	D	D	$11.77
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Pharming Group N.V. ADS, each representing 10 ordinary shares

Pharming Group is a biopharmaceutical company focused on rare and life-threatening diseases with unmet medical needs. It markets RUCONEST for hereditary angioedema (HAE) and Joenja (leniolisib) for activated phosphoinositide 3-kinase delta syndrome, supported by a pipeline of biologic and small-molecule therapies in development.